Patent intelligence · US
US 7148193
Compounds that bind to growth hormone receptor
Compounds that bind to growth hormone receptor
Patent details — US 7148193
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 12, 2006
- Expiration
- Dec 7, 2026
- Applicant
- ANTYRA INC.
- Claims
- 6
- CPC classes
- A61K, A61K38/00
Quick answer
US 7148193 (Compounds that bind to growth hormone receptor) is held by ANTYRA INC.. Status: granted. Granted Dec 12, 2006. Expires Dec 7, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANTYRA INC.
- Grant date
- Expiration
- Claims
- 6
- CPC classes
- A61K, A61K38/00
More from ANTYRA INC.
Related pharmaceutical patents in our USPTO index.
-
US 12290069
Pest control using natural pest control agent blends
granted -
US 12264149
Indazole compounds as kinase inhibitors
granted -
US 12071428
Indazole compounds as kinase inhibitors
granted -
US 12035713
Pest control using natural pest control agent blends
granted -
US 11896007
Pest control using natural pest control agent blends
granted -
US 11116214
Lice control composition and method
granted -
US 10881104
Arthropod control composition, formulation, and method
granted -
US 10799472
Antiparasitic compositions and methods
granted
Frequently asked questions
What is US patent 7148193?
US 7148193 (Compounds that bind to growth hormone receptor) is held by ANTYRA INC.. Status: granted. Granted Dec 12, 2006. Expires Dec 7, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7148193?
ANTYRA INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 17 pharmaceutical patents for this assignee.
When does US 7148193 expire?
Our index shows an expiration date of Dec 7, 2026 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.